Migraine is increasingly recognized as a neurovascular disorder characterized by episodic endothelial dysfunction, transient inflammatory activation (including interleukin-6 and CRP surges), oxidative stress, and—in many patients—hormonal fluctuations. This evidence concerns the gene IL6 and endothelial dysfunction.